Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Cisplatin is one of the most effective and widely used anticancer agents for the treatment of several types of tumors. The cytotoxic effect of cisplatin is thought to be mediated primarily by the generation of nuclear DNA adducts, which, if not repaired, cause cell death as a consequence of DNA replication and transcription blockage. However, the ability of cisplatin to induce nuclear DNA (nDNA) damage per se is not sufficient to explain its high degree of effectiveness nor the toxic effects exerted on normal, post-mitotic tissues. Oxidative damage has been observed in vivo following exposure to cisplatin in several tissues, suggesting a role for oxidative stress in the pathogenesis of cisplatin-induced dose-limiting toxicities. However, the mechanism of cisplatin-induced generation of ROS and their contribution to cisplatin cytotoxicity in normal and cancer cells is still poorly understood. By employing a panel of normal and cancer cell lines and the budding yeast Saccharomyces cerevisiae as model system, we show that exposure to cisplatin induces a mitochondrial-dependent ROS response that significantly enhances the cytotoxic effect caused by nDNA damage. ROS generation is independent of the amount of cisplatin-induced nDNA damage and occurs in mitochondria as a consequence of protein synthesis impairment. The contribution of cisplatin-induced mitochondrial dysfunction in determining its cytotoxic effect varies among cells and depends on mitochondrial redox status, mitochondrial DNA integrity and bioenergetic function. Thus, by manipulating these cellular parameters, we were able to enhance cisplatin cytotoxicity in cancer cells. This study provides a new mechanistic insight into cisplatin-induced cell killing and may lead to the design of novel therapeutic strategies to improve anticancer drug efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, cisplatin, which is one of the most effective and widely used chemotherapeutic agents for various cancers, induces mitochondria‐dependent ROS that contributes to cell death via the formation of nuclear DNA damage.”
From Reactive Oxygen Species in Cancer: Current Findings and Future Directions (2021) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Bonnet, S., Archer, S. L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,530 · cited 3×
“To validate our prediction we used the pyruvate dehydrogenase kinase inhibitor dichloroacetate (DCA) to switch the metabolism of cancer cells from glycolysis to glucose oxidation [44].”
BackgroundMethodInfluentialFichtinger-Schepman, A. M. J., Van der Veer, J. L., Den Hartog, J. H. J., Lohman, P. H. M., & Reedijk, J. (1985) · Biochemistry · doi:10.1021/bi00324a025 · Cited by 1,024
Azzoli, C. G., Baker, S., Temin, S., Pao, W., Aliff, T., Brahmer, J., Johnson, D. H., Laskin, J. L., Masters, G., Milton, D., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.5622 · Cited by 915 · cited 1×
“We used the non-small cell lung cancer cell line A549, as cisplatin-based chemotherapy is a standard of care for this type of tumor [37].”
MethodReview of the Comparative Pharmacology and Clinical Activity of Cisplatin and Carboplatin
Go, R. S., & Adjei, A. A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.409 · Cited by 697 · cited 1×
“To confirm the essential role of mitochondrial protein synthesis impairment in enhancing cisplatin cytotoxicity, we evaluated the effects of another platinum-based drug, carboplatin, which forms similar types of nDNA lesions, but is substantially less toxic than cisplatin [40].”
BackgroundShen, H.-M., & Liu, Z.-G. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.10.056 · Cited by 629 · cited 2×
“have been shown to be activated by ROS and induce cell death [55–57].”
BackgroundMarroquin, L. D., Hynes, J., Dykens, J. A., Jamieson, J. D., & Will, Y. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm052 · Cited by 628 · cited 1×
“Such a metabolic adaptation results in lower susceptibility toward the effects of mitochondrial toxicants on cell viability and growth [64]; therefore, the contribution of cisplatin-induced mitochondrial impairment to its cytotoxic effect may have been underestimated in our study as well as in those performed by other…”
ResultMitochondria as a Target of Environmental Toxicants
Meyer, J. N., Leung, M. C. K., Rooney, J. P., Sendoel, A., Hengartner, M. O., Kisby, G. E., & Bess, A. S. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft102 · Cited by 562
Madesh, M., & Hajnóczky, G. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200105057 · Cited by 538 · cited 1×
“activation of intracellular pro-apoptotic pathways [54–56].”
Reactive oxygen generated by Nox1 triggers the angiogenic switch
Arbiser, J. L., Petros, J., Klafter, R., Govindajaran, B., McLaughlin, E. R., Brown, L. F., Cohen, C., Moses, M., Kilroy, S., Arnold, R. S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022630199 · Cited by 489 · cited 2×
“DU145 and its derivative DU145ρ° prostate cancer cell lines were donated by John Petros, MD, Emory University [28].”
MethodMukhopadhyay, P., Rajesh, M., Haskó, G., Hawkins, B. J., Madesh, M., & Pacher, P. (2007) · Nature Protocols · doi:10.1038/nprot.2007.327 · Cited by 373 · cited 1×
“was carried out as previously described [30] and shown in”
MethodBajorin, D. F., Sarosdy, M. F., Pfister, D. G., Mazumdar, M., Motzer, R. J., Scher, H. I., Geller, N. L., Fair, W. R., Herr, H., & Sogani, P. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.4.598 · Cited by 354 · cited 1×
“In testicular cancer, cisplatin-based combination regimens result in a cure for the majority of the patients, but carboplatin-based regimens are associated with sub-optimal outcomes [52,53]; these observations may be explained by our findings.”
ResultGotoh, Y., & Cooper, J. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17477 · Cited by 352 · cited 2×
“have been shown to be activated by ROS and induce cell death [55–57].”
BackgroundHitosugi, T., Fan, J., Chung, T.-W., Lythgoe, K., Wang, X., Xie, J., Ge, Q., Gu, T.-L., Polakiewicz, R. D., Roesel, J. L., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.10.015 · Cited by 334 · cited 1×
“Moreover, the Warburg effect is often sustained by oncogene-driven pathways that are altered in cancer cells and that may constitute ideal “druggable’ targets for the development of sensitizers for cisplatin treatment [65].”
BackgroundHorwich, A., Sleijfer, D. T., Fosså, S. D., Kaye, S. B., Oliver, R. T., Cullen, M. H., Mead, G. M., de Wit, R., de Mulder, P. H., Dearnaley, D. P., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.1844 · Cited by 333
DNA damage-induced reactive oxygen species (ROS) stress response in Saccharomyces cerevisiae
Rowe, L. A., Degtyareva, N., & Doetsch, P. W. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.07.018 · Cited by 330 · cited 1×
“μg/mL; Molecular Probes) as previously described [33].”
Self-citationEmerling, B. M., Weinberg, F., Snyder, C., Burgess, Z., Mutlu, G. M., Viollet, B., Budinger, G. R. S., & Chandel, N. S. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.019 · Cited by 330 · cited 1×
“have been shown to be activated by ROS and induce cell death [55–57].”
BackgroundSantos, N. A. G., Catão, C. S., Martins, N. M., Curti, C., Bianchi, M. L. P., & Santos, A. C. (2007) · Archives of Toxicology · doi:10.1007/s00204-006-0173-2 · Cited by 327 · cited 1×
“normal cells [21–23] and treatment with antioxidants”
Cisplatin induced Mitochondrial DNA damage in dorsal root ganglion neurons
Podratz, J. L., Knight, A. M., Ta, L. E., Staff, N. P., Gass, J. M., Genelin, K., Schlattau, A., Lathroum, L., & Windebank, A. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.11.017 · Cited by 320 · cited 1×
“Mitochondrial damage has been observed in several models of cisplatin induced nephrotoxicity and neurotoxicity [16,45–48] and targeted delivery of antioxidants to mitochondria reduces the onset of cisplatin-induced renal cell damage [49].”
BackgroundDNA damage induces reactive oxygen species generation through the H2AX-Nox1/Rac1 pathway
Kang, M. A., So, E.-Y., Simons, A. L., Spitz, D. R., & Ouchi, T. (2012) · Cell Death & Disease · doi:10.1038/cddis.2011.134 · Cited by 311 · cited 1×
“[33,38].”
Architectural Role of Mitochondrial Transcription Factor A in Maintenance of Human Mitochondrial DNA
Kanki, T., Ohgaki, K., Gaspari, M., Gustafsson, C. M., Fukuoh, A., Sasaki, N., Hamasaki, N., & Kang, D. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.22.9823-9834.2004 · Cited by 306 · cited 1×
“TFAM is a mitochondrial transcription factor that regulates mtDNA transcription and replication [41].”
BackgroundNovel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol γ
Achanta, G., Sasaki, R., Feng, L., Carew, J. S., Lu, W., Pelicano, H., Keating, M. J., & Huang, P. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600819 · Cited by 285 · cited 1×
“previously described [34].”
Yang, Z., Schumaker, L. M., Egorin, M. J., Zuhowski, E. G., Guo, Z., & Cullen, K. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1037 · Cited by 267
d-Methionine provides excellent protection from cisplatin ototoxicity in the rat
Campbell, K. C. M., Rybak, L. P., Meech, R. P., & Hughes, L. (1996) · Hearing Research · doi:10.1016/s0378-5955(96)00152-9 · Cited by 240 · cited 1×
“[24–27], suggesting an involvement of oxidative stress in the”
BackgroundInteractions between mammalian cell DNA and inorganic platinum compounds—I
Pascoe, J. M., & Roberts, J. J. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90354-2 · Cited by 236
Hansson, A., Hance, N., Dufour, E., Rantanen, A., Hultenby, K., Clayton, D. A., Wibom, R., & Larsson, N.-G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308710100 · Cited by 220 · cited 1×
“TFAM deficiency results in reduced respiratory chain function and increased expression of glycolytic enzymes [42].”
BackgroundPinto, A. L., & Lippard, S. J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.14.4616 · Cited by 219 · cited 1×
“apoptosis [6–10].”
Martins, N. M., Santos, N. A. G., Curti, C., Bianchi, M. L. P., & Santos, A. C. (2008) · Journal of Applied Toxicology · doi:10.1002/jat.1284 · Cited by 212 · cited 1×
“Although other groups have reported that cisplatin exposure results in mitochondrial injury and energy imbalance [50,51] in cancer cells, the mechanism of cisplatin-induced mitochondrial impairment and subsequent ROS generation has not been previously characterized.”
BackgroundMukhopadhyay, P., Horváth, B., Zsengellér, Z., Zielonka, J., Tanchian, G., Holovac, E., Kechrid, M., Patel, V., Stillman, I. E., Parikh, S. M., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.001 · Cited by 209 · cited 1×
“Mitochondrial damage has been observed in several models of cisplatin induced nephrotoxicity and neurotoxicity [16,45–48] and targeted delivery of antioxidants to mitochondria reduces the onset of cisplatin-induced renal cell damage [49].”
BackgroundSwanson, R. L., Morey, N. J., Doetsch, P. W., & Jinks-Robertson, S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2929 · Cited by 206 · cited 1×
“ade2-101oc his3Δ200 ura3ΔNco lys2ΔBgl leu2-R) and SJR868 (MATa ade2-101oc his3Δ200 ura3DNco lys2ΔBgl leu2-R rad1Δ::hisG) [31].”
Self-citationCiccarelli, R. B., Solomon, M. J., Varshavsky, A., & Lippard, S. J. (1985) · Biochemistry · doi:10.1021/bi00347a005 · Cited by 205 · cited 1×
“apoptosis [6–10].”
Melli, G., Taiana, M., Camozzi, F., Triolo, D., Podini, P., Quattrini, A., Taroni, F., & Lauria, G. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.08.013 · Cited by 202
Mitochondrial Stress Engages E2F1 Apoptotic Signaling to Cause Deafness
Raimundo, N., Song, L., Shutt, T. E., McKay, S. E., Cotney, J., Guan, M.-X., Gilliland, T. C., Hohuan, D., Santos-Sacchi, J., & Shadel, G. S. (2012) · Cell · doi:10.1016/j.cell.2011.12.027 · Cited by 189 · cited 1×
“In particular, the AMP-activated protein kinase (AMPK) has recently been shown to promote apoptosis specifically in neurons of the inner ear by a mechanism where impairment in mitochondrial protein synthesis results in ROS generation [58].”
BackgroundSodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC
Stockwin, L. H., Yu, S. X., Borgel, S. D., Hancock, C. N., Wolfe, T. L., Phillips, L. R., Hollingshead, M. G., & Newton, D. L. (2010) · International Journal of Cancer · doi:10.1002/ijc.25499 · Cited by 175 · cited 1×
“5 expression levels are controversial [62].”
Santos, N. A. G., Bezerra, C. S. C., Martins, N. M., Curti, C., Bianchi, M. L. P., & Santos, A. C. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0459-y · Cited by 165 · cited 1×
“[24–27], suggesting an involvement of oxidative stress in the”
BackgroundMitochondrial Genome Instability and ROS Enhance Intestinal Tumorigenesis in APC Mice
Woo, D. K., Green, P. D., Santos, J. H., D’Souza, A. D., Walther, Z., Martin, W. D., Christian, B. E., Chandel, N. S., & Shadel, G. S. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.10.003 · Cited by 154 · cited 5×
“DU145 and its derivative DU145ρ° prostate cancer cell lines were donated by John Petros, MD, Emory University [28].”
BackgroundMethodInfluentialOxidative DNA Damage Causes Mitochondrial Genomic Instability in Saccharomyces cerevisiae
Doudican, N. A., Song, B., Shadel, G. S., & Doetsch, P. W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.5196-5204.2005 · Cited by 150 · cited 1×
“were generated by incubating cells in ethidium bromide as previously described [32].”
MethodSelf-citationThe role of apoptosis in cell killing by cisplatin: a flow cytometric study
Ormerod, M., Rm, O., & Peacock, J. H. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.14 · Cited by 148
Cisplatin Ototoxicity: Involvement of Iron and Enhanced Formation of Superoxide Anion Radicals
Dehne, N., Lautermann, J., Petrat, F. M., Rauen, U., & de GROOT, H. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9171 · Cited by 148 · cited 1×
“normal cells [21–23] and treatment with antioxidants”
The nephrotoxic effects of cis-diammine-dichloroplatinum (II) (NSC-119875) in male F344 rats
Ward, J. M., & Fauvie, K. A. (1976) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(76)90185-x · Cited by 146
Multisite control of the Crabtree effect in ascites hepatoma cells
Rodríguez‐Enríquez, S., Juárez, O. X., Rodríguez‐Zavala, J. S., & Moreno‐Sánchez, R. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02140.x · Cited by 144 · cited 1×
“Although routinely used for similar studies, immortalized cell lines grown in these conditions derive their energy mainly from glycolysis rather than mitochondrial oxidation, independently of the presence of fully functional mitochondria (Crabtee effect) [63].”
BackgroundInteractions between mammalian cell DNA and inorganic platinum compounds—II
Pascoe, J. M., & Roberts, J. J. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90355-4 · Cited by 140
Jiang, Y., Guo, C., Vasko, M. R., & Kelley, M. R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1173 · Cited by 135 · cited 1×
“normal cells [21–23] and treatment with antioxidants”
Mitochondrial density determines the cellular sensitivity to cisplatin-induced cell death
Qian, W., Nishikawa, M., Haque, A. M., Hirose, M., Mashimo, M., Sato, E. F., & Inoue, M. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00265.2005 · Cited by 133
Rodrı́guez, A. M., Carrico, P. M., Mazurkiewicz, J. E., & Melendez, J. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00362-2 · Cited by 130
Mitochondrial injury: an early event in cisplatin toxicity to renal proximal tubules
Brady, H. R., Kone, B. C., Stromski, M. E., Zeidel, M. L., Giebisch, G., & Gullans, S. R. (1990) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1990.258.5.f1181 · Cited by 129 · cited 1×
“Mitochondrial damage has been observed in several models of cisplatin induced nephrotoxicity and neurotoxicity [16,45–48] and targeted delivery of antioxidants to mitochondria reduces the onset of cisplatin-induced renal cell damage [49].”
BackgroundHuman tissue distribution of platinum after cis-diamminedichloroplatinum
Stewart, D., Benjamin, R., Luna, M. A., Feun, L. G., Caprioli, R. M., Seifert, W. E., & Loo, T. L. (1982) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00257239 · Cited by 126
Zsengellér, Z. K., Ellezian, L., Brown, D. A., Horváth, B., Mukhopadhyay, P., Kalyanaraman, B., Parikh, S. M., Karumanchi, S. A., Stillman, I. E., & Pacher, P. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155412446227 · Cited by 125 · cited 1×
“Mitochondrial damage has been observed in several models of cisplatin induced nephrotoxicity and neurotoxicity [16,45–48] and targeted delivery of antioxidants to mitochondria reduces the onset of cisplatin-induced renal cell damage [49].”
BackgroundLee, K. B., Parker, R. J., Bohr, V. A., Cornelison, T. L., & Reed, E. (1993) · Carcinogenesis · doi:10.1093/carcin/14.10.2177 · Cited by 101 · cited 1×
“NER activity are extremely sensitive to cisplatin [4,5].”
BackgroundMello, J. A., Lippard, S. J., & Essigmann, J. M. (1995) · Biochemistry · doi:10.1021/bi00045a020 · Cited by 101
Stadnicki, S. W., Rw, F., Schaeppi, U. H., & Merriam, P. (1975) · PubMed · Cited by 96
Mitochondrial alterations in cisplatin-induced acute renal failure
Gordon, J. A., & Gattone, V. H. (1986) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1986.250.6.f991 · Cited by 95
El-Beshbishy, H. A., Bahashwan, S., Aly, H. A. A., & Fakher, H. A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.06.051 · Cited by 94 · cited 1×
“[24–27], suggesting an involvement of oxidative stress in the”
BackgroundOlivero, O. A., Chang, P. K., López‐Larraza, D. M., Semino-Mora, M. C., & Poirier, M. C. (1997) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s0165-1218(97)00037-2 · Cited by 83
Li, C.-H., Cheng, Y., Liao, P.-L., Yang, Y.-T., & Kang, J. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq085 · Cited by 82 · cited 1×
“As a positive control, we assessed the cellular expression of ETC proteins following exposure to chloramphenicol, an antibiotic that inhibits mitochondrial protein translation [39].”
Hour, T., Lai, Y., Kuan, C.-I., Chou, C., Wang, J., Tu, H.-Y., Hu, H., Lin, C., Wu, W., Pu, Y., et al. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.04.007 · Cited by 71 · cited 1×
“Accordingly, other groups observed increased expression of ROS scavenging enzymes in cisplatin-resistant cancer cells compared to normal cells [59–61]; thus, our findings may serve as a framework to uncover new mechanisms for cisplatin resistance in cancer cells.”
BackgroundEvaluation of cis-diamminedichloroplatinum (II) (cisplatin) neurotoxicity in rats
Koning, P. D., Neijt, J. P., Jennekens, F. G. I., & Gispen, W. H. (1987) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(87)90178-5 · Cited by 70 · cited 1×
“cells in kidney, ear and sensory nerves [11–13].”
BackgroundBeljanski, V., Marzilli, L. G., & Doetsch, P. W. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1496 · Cited by 66 · cited 1×
“NER activity are extremely sensitive to cisplatin [4,5].”
BackgroundSelf-citationBártková, J., Zemanova, M., & Bartek, J. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960611)66:6<779::aid-ijc12>3.0.co;2-z · Cited by 62 · cited 1×
“cisplatin-nDNA adducts [3]; therefore, cells with compromised”
Mechanism of toxicity of platinum(II) compounds in repair-deficient strains of Escherichia coli
Alazard, R. J., Germanier, M., & Johnson, N. P. (1982) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(82)90148-8 · Cited by 59 · cited 1×
“apoptosis [6–10].”
Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer
Brown, D. P. G., Chin-Sinex, H., Nie, B., Mendonca, M. S., & Wang, M. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0791-x · Cited by 57 · cited 1×
“Accordingly, other groups observed increased expression of ROS scavenging enzymes in cisplatin-resistant cancer cells compared to normal cells [59–61]; thus, our findings may serve as a framework to uncover new mechanisms for cisplatin resistance in cancer cells.”
BackgroundUncoupling protein-2 knockdown mediates the cytotoxic effects of cisplatin
Santandreu, F. M., Roca, P., & Oliver, J. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.05.031 · Cited by 50 · cited 1×
“Although other groups have reported that cisplatin exposure results in mitochondrial injury and energy imbalance [50,51] in cancer cells, the mechanism of cisplatin-induced mitochondrial impairment and subsequent ROS generation has not been previously characterized.”
BackgroundProteomic Analyses of Sirt1-Mediated Cisplatin Resistance in OSCC Cell Line
Xiong, P., Li, Y., Tang, Y.-T., & Chen, H.-G. (2011) · The Protein Journal · doi:10.1007/s10930-011-9354-9 · Cited by 44
Liang, B. C., & Ullyatt, E. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400401 · Cited by 44
Yen, H., TANG, Y., Chen, F.-Y., CHEN, S., & Majima, H. J. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1338.047 · Cited by 26 · cited 1×
“with controversial results [16,18–20].”
Cited by
ROS and the DNA damage response in cancer
Srinivas, U. S., Tan, B. W. Q., Vellayappan, B. A., & Jeyasekharan, A. D. (2019) · Redox Biology · doi:10.1016/j.redox.2018.101084 · Cited by 2,144
“In addition to generating nuclear DNA adducts, platinum drugs increase mtROS via formation of mitochondrial DNA adducts [104–106], the extent of which correlates with cytotoxicity [24,107].”
BackgroundROS homeostasis and metabolism: a dangerous liason in cancer cells
Panieri, E., & Santoro, M. M. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.105 · Cited by 1,151
Reactive Oxygen Species in Cancer: Current Findings and Future Directions
Nakamura, H., & Takada, K. (2021) · Cancer Science · doi:10.1111/cas.15068 · Cited by 1,027
Oxidative Stress in Human Pathology and Aging: Molecular Mechanisms and Perspectives
Hajam, Y. A., Rani, R., Ganie, S. Y., Sheikh, T. A., Javaid, D., Qadri, S. S., Pramodh, S., Alsulimani, A., Alkhanani, M. F., Harakeh, S., et al. (2022) · Cells · doi:10.3390/cells11030552 · Cited by 915
Glutaminolysis: A Hallmark of Cancer Metabolism
Yang, L., Venneti, S., & Nagrath, D. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044546 · Cited by 859
“CAFs: cancer-associated fibroblasts and induces apoptosis (Figure 7a) (107, 108).”
Background
Metadata
- Authors
- Marullo, R., Werner, E., Degtyareva, N., Moore, B., Altavilla, G., Ramalingam, S. S., & Doetsch, P. W.
- Affiliations
- University of Messina (IT)
- Emory University (US)
- Geisinger Medical Center (US)
- Corresponding author
- Doetsch, Paul W.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-11-19
- Volume
- 8
- Issue
- 11
- Pages
- e81162
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3834214
- OpenAlex
- W1987702513
- Cited by
- 777
- References
- 67
- Citations by year
- 2026: 44 · 2025: 61 · 2024: 63 · 2023: 64 · 2022: 102 · 2021: 81 · 2020: 86 · 2019: 82 · 2018: 57 · 2017: 50 · 2016: 37 · 2015: 33 · 2014: 15
- FWCI
- 12.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institute of Environmental Health Sciences (P01ES011163, ES011163)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- cisplatin, reactive oxygen species, mitochondrial dysfunction, oxidative stress, cisplatin cytotoxicity, mitochondrial redox status, mitochondrial DNA integrity, mitochondrial bioenergetics, DNA damage, anticancer drug toxicity, Saccharomyces cerevisiae
- MeSH terms
- Animals, Antineoplastic Agents, Cell Nucleus, Cisplatin, DNA, DNA Damage, DNA Repair, Humans, Mitochondria, Oxidation-Reduction, Saccharomyces cerevisiae, Apoptosis, Reactive Oxygen Species, DNA Adducts, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.